BRPI0811777A2 - partículas de ácido hialurõnico revestidas - Google Patents

partículas de ácido hialurõnico revestidas

Info

Publication number
BRPI0811777A2
BRPI0811777A2 BRPI0811777A BRPI0811777A BRPI0811777A2 BR PI0811777 A2 BRPI0811777 A2 BR PI0811777A2 BR PI0811777 A BRPI0811777 A BR PI0811777A BR PI0811777 A BRPI0811777 A BR PI0811777A BR PI0811777 A2 BRPI0811777 A2 BR PI0811777A2
Authority
BR
Brazil
Prior art keywords
hyaluronic acid
acid particles
coated hyaluronic
coated
particles
Prior art date
Application number
BRPI0811777A
Other languages
English (en)
Inventor
Tezel Ahmet
A Champion Julie
Mitragotri Samir
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0811777A2 publication Critical patent/BRPI0811777A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
BRPI0811777A 2007-05-23 2008-05-21 partículas de ácido hialurõnico revestidas BRPI0811777A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93965907P 2007-05-23 2007-05-23
PCT/US2008/064378 WO2008147817A2 (en) 2007-05-23 2008-05-21 Coated hyaluronic acid particles

Publications (1)

Publication Number Publication Date
BRPI0811777A2 true BRPI0811777A2 (pt) 2019-09-24

Family

ID=39645603

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811777A BRPI0811777A2 (pt) 2007-05-23 2008-05-21 partículas de ácido hialurõnico revestidas

Country Status (7)

Country Link
US (2) US20090022808A1 (pt)
EP (1) EP2162158A2 (pt)
JP (1) JP2010528039A (pt)
AU (1) AU2008256864A1 (pt)
BR (1) BRPI0811777A2 (pt)
CA (1) CA2687983A1 (pt)
WO (1) WO2008147817A2 (pt)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
US20060073208A1 (en) * 2004-10-01 2006-04-06 Allergan, Inc. Cosmetic neurotoxin compositions and methods
EP2152743A2 (en) * 2007-05-23 2010-02-17 Allergan, Inc. Cross-linked collagen and uses thereof
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
EP2818184B1 (en) 2007-11-16 2018-10-31 Allergan, Inc. Compositions and methods for treating Purpura
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8668863B2 (en) 2008-02-26 2014-03-11 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
WO2010028025A1 (en) 2008-09-02 2010-03-11 Gurtner Geoffrey C Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
JP4885245B2 (ja) * 2009-01-15 2012-02-29 日本航空電子工業株式会社 Ｒｄコンバータ及び角度検出装置
EP2435083A2 (en) * 2009-05-29 2012-04-04 Galderma Research & Development Combination of adrenergic receptor agonist -1 or -2, preferably brimonidine with fillers, preferablyhyaluronic acid
FR2948286B1 (fr) 2009-07-27 2011-08-26 Jean-Noel Thorel Composition injectable associant un agent de comblement et un milieu de croissance des fibroblastes
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
US20110171310A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
FR2955258A1 (fr) 2010-01-20 2011-07-22 Biopharmex Holding Ltd Composition injectable
EP2544652A2 (en) * 2010-03-12 2013-01-16 Allergan Industrie SAS A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition.
EP3520827B1 (en) 2010-03-22 2022-05-25 Allergan, Inc. Cross-linked hydrogels for soft tissue augmentation
EP2404993A1 (en) * 2010-07-09 2012-01-11 Merz Pharma GmbH & Co. KGaA Alginate filler including eukaryotic cells
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
WO2012048289A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
WO2012048283A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9149422B2 (en) 2011-06-03 2015-10-06 Allergan, Inc. Dermal filler compositions including antioxidants
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US20150252120A1 (en) 2012-10-09 2015-09-10 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Modified hyaluronic acid derivatives and use thereof
EP2931327B1 (en) 2012-12-11 2019-02-13 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
JP6322192B2 (ja) * 2013-07-08 2018-05-09 デンカ株式会社 コアシェル型架橋ヒアルロン酸ゲル粒子、その製造方法及び医用材料
WO2015018461A1 (fr) 2013-08-09 2015-02-12 Genbiotech Compositions therapeutiques comprenant d'acide hyaluronique
PL3089732T3 (pl) * 2013-12-31 2023-12-27 Pb&B Sa Kompozycje o kontrolowanym uwalnianiu kwasów tłuszczowych do stosowania w rekonstrukcji i kształtowaniu sylwetki
US20150209265A1 (en) * 2014-01-27 2015-07-30 Allergan Holdings France S.A.S. Spherical forms of cross-linked hyaluronic acid and methods of use thereof
WO2016025945A1 (en) 2014-08-15 2016-02-18 The Johns Hopkins University Technology Ventures Composite material for tissue restoration
EP3200838B1 (en) 2014-09-30 2019-09-18 Allergan Industrie, SAS Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
WO2016128550A1 (en) 2015-02-13 2016-08-18 Allergan Industrie, Sas Implants for sculpting, augmenting or correcting facial features such as the chin
KR101781288B1 (ko) * 2016-01-26 2017-09-26 서울과학기술대학교 산학협력단 친수성 고분자 및 소수성 고분자를 포함하는 하이드로젤 입자 및 그의 제조방법
WO2018102480A1 (en) * 2016-11-30 2018-06-07 Brown University Methods of fabricating hyper compliant polymer particles and methods of use and compositions
KR101879065B1 (ko) * 2016-12-12 2018-07-17 구태훈 구형 입자를 갖는 연조직용 필러 및, 그 제조방법
KR102363007B1 (ko) * 2017-01-18 2022-02-14 구태훈 모노-페이직 ha 필러의 특성과 바이-페이직 ha 필러의 특성을 함께 갖는 ha 필러, 필러 주입에 사용되는 주사기 및, 필러의 제조방법
KR101769739B1 (ko) * 2017-01-18 2017-08-21 구태훈 모노-페이직 ha 필러의 특성과 바이-페이직 ha 필러의 특성을 함께 갖는 ha 필러, 필러 주입에 사용되는 주사기 및, 필러의 제조방법
US11980700B2 (en) 2017-03-08 2024-05-14 Alafair Biosciences, Inc. Hydrogel medium for the storage and preservation of tissue
EP3752097B1 (en) * 2018-02-18 2023-11-01 G&G Biotechnology Ltd. Implants with enhanced shell adhesion
WO2019191405A1 (en) * 2018-03-29 2019-10-03 Ayyala Ramesh S Methods and compositions for delivery of a therapeutic agent
CN112334168B (zh) 2018-05-03 2024-10-22 科尔普兰特有限公司 真皮填充剂和其应用
JP2021522938A (ja) * 2018-05-09 2021-09-02 ザ ジョンズ ホプキンス ユニバーシティ 細胞及び組織の送達のためのナノファイバー−ハイドロゲル複合体
KR20210034544A (ko) * 2018-05-09 2021-03-30 더 존스 홉킨스 유니버시티 향상된 연조직 대체 및 재생을 위한 나노섬유-하이드로겔 복합재료
CN110575564B (zh) * 2019-09-30 2020-05-08 张勇 用于医学整形美容的填充物及其制备方法和应用
CN117858734A (zh) * 2021-05-13 2024-04-09 上海其胜生物制剂有限公司 含有可缓慢吸收聚合物的透明质酸组合物
EP4395796A4 (en) 2021-09-01 2024-12-25 Shanghai Qisheng Biological Preparation Co., Ltd. Cartilage regeneration using injectable, in situ polymerizable collagen compositions containing chondrocytes or stem cells
WO2023125689A1 (en) 2021-12-28 2023-07-06 Shanghai Qisheng Biological Preparation Co., Ltd. Hyaluronic acid-collagen copolymer compositions and medical applications thereof
CN115721615B (zh) * 2022-11-17 2024-08-30 华熙生物科技股份有限公司 一种透明质酸颗粒及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2128827A (en) * 1938-03-09 1938-08-30 Frank B Killian Method and apparatus for manufacturing thin rubber articles
US5643464A (en) * 1988-11-21 1997-07-01 Collagen Corporation Process for preparing a sterile, dry crosslinking agent
NZ259574A (en) * 1993-01-20 1997-05-26 Squibb & Sons Inc Alginate fibres, fabric and wound dressing with specific thermal and absorbency properties
US6214331B1 (en) * 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
JPH11507679A (ja) * 1995-06-06 1999-07-06 シー．アール．バード，インコーポレイティド 水溶性ポリマーの粒子の水性分散液の製造法および得られた粒子
US6007843A (en) * 1995-09-29 1999-12-28 Lam Pharmaceuticals Corp. Sustained release delivery system
US5935164A (en) * 1997-02-25 1999-08-10 Pmt Corporaton Laminated prosthesis and method of manufacture
FR2764514B1 (fr) * 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
US6767928B1 (en) * 1999-03-19 2004-07-27 The Regents Of The University Of Michigan Mineralization and biological modification of biomaterial surfaces
US6773723B1 (en) * 2000-08-30 2004-08-10 Depuy Acromed, Inc. Collagen/polysaccharide bilayer matrix
US6620196B1 (en) * 2000-08-30 2003-09-16 Sdgi Holdings, Inc. Intervertebral disc nucleus implants and methods
ATE409465T1 (de) * 2000-10-06 2008-10-15 Pacira Pharmaceuticals Inc Parenteral verabreichbare mikropartikel- zubereitung mit kontrollierter freisetzung
US6599627B2 (en) * 2000-12-13 2003-07-29 Purdue Research Foundation Microencapsulation of drugs by solvent exchange
US6979440B2 (en) * 2001-01-29 2005-12-27 Salvona, Llc Compositions and method for targeted controlled delivery of active ingredients and sensory markers onto hair, skin, and fabric
EP1534215A1 (en) * 2002-07-02 2005-06-01 Procyte Corporation Compositions containing peptide copper complexes and soft tissue fillers
US6780366B2 (en) * 2002-08-15 2004-08-24 Mentor Corporation Drip retainer
KR100523953B1 (ko) * 2002-08-27 2005-10-25 주식회사 엘지생명과학 천연다당류와 히알루론산의 마이크로비드 및 이의 제조 방법
TWI251596B (en) * 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
WO2006002050A1 (en) * 2004-06-15 2006-01-05 Encore Therapeutics, Inc. Phospholipid compositions and methods for their preparation and use
EP1726299A3 (en) * 2005-05-27 2007-04-18 StratoSphere Pharma AB Cores and microcapsules suitable for parenteral administration as well as process for their manufacture

Also Published As

Publication number Publication date
CA2687983A1 (en) 2008-12-04
US20090022808A1 (en) 2009-01-22
WO2008147817A2 (en) 2008-12-04
WO2008147817A3 (en) 2009-11-05
AU2008256864A1 (en) 2008-12-04
JP2010528039A (ja) 2010-08-19
US20100217403A1 (en) 2010-08-26
EP2162158A2 (en) 2010-03-17

Similar Documents

Publication Publication Date Title
BRPI0811777A2 (pt) partículas de ácido hialurõnico revestidas
BRPI0815045A2 (pt) Composições de ácido hialurônico ajustavelmente reticuladas
BRPI0922181A2 (pt) partículas de anti-corrosivo
DK2188125T3 (da) Fotokatalytisk coating
EP2220009A4 (en) Anti-tarnish coating
EP2310144A4 (en) COATINGS
FI20060288A0 (fi) Pinnoitusmenetelmä
BRPI0808118A2 (pt) Revestimento hidrófilo
BRPI0808105A2 (pt) Revestimento hidrófilo
BRPI0717071A2 (pt) artigo revestido
EP2350710A4 (en) REFLECTING FOIL
BRPI0917186A2 (pt) partículas sólidas revestidas
BRPI0717211A2 (pt) artigo revestido
DE602007013995D1 (de) Beschichtungsverfahren
BRPI0908116A2 (pt) pulverizador
EP2251092A4 (en) ELECTROSTATIC SPRAYER
EP2152937A4 (en) COATING
DK2379018T3 (da) Proteseovertræk
EP2246120A4 (en) ELECTROSTATIC SPRAYER
EP2321062A4 (en) Sprayer
EP2140851A4 (en) ELECTROSTATIC SPRAYER
BRPI0815649A2 (pt) Revestimento
BRPI0821976A2 (pt) composições de revestimentos de fotocatalítico
EP2112208A4 (en) COATING COMPOSITION
EP2135903A4 (en) COATING AGENT

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.